News
- Author:
- Will Pass
Publish date: February 6, 2020
The score, which combines sex, age, alpha-fetoprotein-L3, alpha-fetoprotein, and des-gamma-carboxyprothrombin is blood based and can replace ultras...
News
- Author:
- Will Pass
Publish date: February 5, 2020
Patients with circulating tumor cells were three times more likely to have disease recurrence within 6 months.
News
- Author:
- Will Pass
Publish date: January 29, 2020
The manometric esophageal length-to-height ratio could offer a means of preoperatively identifying shortened esophagus.
News
- Author:
- Will Pass
Publish date: January 26, 2020
Alternative analgesics should be considered for patients with inflammatory bowel disease.
News
- Author:
- Will Pass
Publish date: January 22, 2020
The overall response rate to the anti-CD20 antibody was 72%, of which 53% were partial and 19% were complete.
News
- Author:
- Will Pass
Publish date: January 21, 2020
Almost one out of five patients may have notably worse cognitive and psychiatric outcomes within 1-5 years of the...
News
- Author:
- Will Pass
Publish date: January 14, 2020
Patients with high-risk disease who underwent prostatectomy also reported worse sexual function at every time point over 5 years.
News
- Author:
- Will Pass
Publish date: January 9, 2020
The sensitivity of circulating tumor DNA for recurrence was 66.0%, compared with 31.9% for carcinoembryonic antigen, in an observational study invo...
News
- Author:
- Will Pass
Publish date: January 7, 2020
In males but not females, hyperinsulinemia, insulin resistance, and metabolic syndrome are independently associated with a higher risk of Barrett’s...
News
- Author:
- Will Pass
Publish date: January 6, 2020
The update offers best practice advice for a range of clinical scenarios based on published evidence.
News
- Author:
- Will Pass
Publish date: January 3, 2020
The guidelines are the first of their kind to be published in the United States.
News
- Author:
- Will Pass
Publish date: January 2, 2020
Investigators divided muscle-invasive bladder cancer into six molecular classes based on disease factors and those consensus classes predicted over...
News
- Author:
- Will Pass
Publish date: December 26, 2019
SAN ANTONIO – The plasmaMATCH trial showed that gene level agreement between ctDNA results measured by digital PCR versus sequencing was as high as...
News
- Author:
- Will Pass
Publish date: December 20, 2019
SAN ANTONIO – When plasma and tumor tissue samples were taken within 60 days of one another, sensitivity of ctDNA testing was 98% for digital dropl...
News
- Author:
- Will Pass
Publish date: December 20, 2019
SAN ANTONIO – Platinum-based chemotherapy was associated with an 18% pCR rate, compared with 26% for standard AC among newly diagnosed HER2-negativ...
